Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 34.08M | $298.0M | 3.24% | +7.74M | 2026-06-30 |
| STATE STREET CORP | 21.40M | $187.0M | 2.03% | +3.69M | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 17.86M | $156.0M | 1.70% | +1.54M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 15.69M | $137.0M | 1.49% | +563.9K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 11.55M | $101.0M | 1.10% | -1.02M | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 11.10M | $97.0M | 1.05% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 9.85M | $86.0M | 0.94% | +1.82M | 2026-06-30 |
| CITADEL ADVISORS LLC | 5.67M | $49.0M | 0.54% | +538.8K | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 5.58M | $48.0M | 0.53% | +4.14M | 2026-06-30 |
| LMR Partners LLP | 4.25M | $37.0M | 0.40% | -93.8K | 2026-06-30 |
